endpoints.news
is our new home on June 1. endpts.com will still work, but the front door is now
https://endpoints.news
Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Law channel feed
Eli Lilly sues four telehealth companies selling compounded tirzepatide
5 weeks ago
Pharma
Health Tech
Recent FDA staff cuts to delay drug hearing decision by months, agency tells Vanda
Last month
FDA+
Alvogen unit appeals court loss shielding Bausch Health's IBS drug from generics
Last month
Pharma
FDA+
Pharma's wins and losses in Trump's sprawling executive order on drug prices
Last month
Pharma
FDA+
Trump pledges his support for a change to the IRA long sought by drugmakers
Last month
Pharma
Sandoz sues Amgen over nine-year launch delay for Enbrel biosimilar
Last month
Pharma
FDA+
Primate researchers cope with uncertainty as NIH appeals for payment cuts in court
Last month
R&D
Pharma
Firings of HHS' probationary workers can proceed, appeals court says
Last month
FDA+
House panel mulls ways to boost struggling US biosimilar market
Last month
FDA+
NIH appeals nationwide block on payment cap for research grantees
Last month
Pharma
Could Kennedy's FDA cuts trigger an obscure clawback provision for industry user fees?
Last month
FDA+
Novo Nordisk, HHS clash over ‘negotiation-eligible’ drugs in IRA appeals fight
Last month
Pharma
HHS says it may revisit anti-obesity drug policies after dropping Biden-era proposal
Last month
Pharma
Marketing
Minnesota federal judge dismisses challenge from AbbVie, AstraZeneca to state's 340B law
Last month
Pharma
GSK and Pfizer resolve RSV vaccine patent fight
Last month
Pharma
FTC chairman seeks to revive PBM case
Last month
Pharma
States sue NIH over 'devastating' grant disruptions amid health agency shakeup
Last month
Pharma
Kennedy team defends Marks firing, while 20% of staff cuts may be 'mistakes'
Last month
FDA+
FTC's fight against PBMs is paused
Last month
Pharma
Updated: J&J’s third talc bankruptcy bid is stopped by Texas federal judge
Last month
Pharma
Federal judge nixes FDA's lab-developed test rule, says it exceeded agency's authority
Last month
Pharma
DC court sides with HHS in Vertex's fertility program fight
Last month
Pharma
Cell/Gene Tx
Judge tosses Amgen's challenge to Colorado drug review board, says suit is 'too speculative'
Last month
Pharma
J&J beats Viatris in patent fight over its antipsychotic drug, staving off competition
Last month
Pharma
First page
Previous page
1
2
3
4
5
Next page
Last page